Abnormal Wnt signaling can lead to TACC3 overexpression; intracellular free β-catenin enters the nucleus, activating oncogenes such as p53 and Ras. Therefore, inhibiting TACC3 expression in tumor cells also inhibits the p53 signaling pathway and reverses G1 phase arrest in these cells. Here, TACC3 is linked to neoplasm.